0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Effective Reduction in the Serum 1,25-Dihydroxyvitamin D and Calcium Concentration in Sarcoidosis-Associated Hypercalcemia with Short-Course Chloroquine Therapy

John S. Adams, MD; Marie M. Diz, BS; and Om P. Sharma, MD
[+] Article and Author Information

Grant Support: Supported in part by grants DK33139 and M01-RR-43 from the National Institutes of Health.

Requests for Reprints: John S. Adams, Cedars-Sinai Medical Center, Endocrinology Department, 8700 Beverly Boulevard, Los Angeles, CA 90048.

Current Author Addresses: Dr. Adams and Ms. Diz: Cedars-Sinai Medical Center, Endocrinology Department, 8700 Beverly Boulevard, Los Angeles, CA 90048.

Dr. Sharma: LAC/USC Medical Center, GHN 11-900, 1200 North State Street, Los Angeles, CA 90033.


Ann Intern Med. 1989;111(5):437-438. doi:10.7326/0003-4819-111-5-437
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

The chronic administration of drugs of the 4-amino quinoline class, including quinacrine, chloroquine, and hydroxychloroquine, has been used for many years to effectively manage many of the cutaneous (1) and extracutaneous symptoms (2) of sarcoidosis. More recently chloroquine (3) and hydroxychloroquine (4) were shown to reduce the extrarenal synthesis of 1,25-dihydroxyvitamin D (l,25-(OH)2-D) and to lower the serum calcium concentration and fractional urinary calcium excretion rate in hypercalcemic-hypercalciuric patients with sarcoidosis. These reports (3, 4) claim that the 1,25-(OH)2-D and calcium lowering effect of these drugs requires weeks, if not months, of therapy. However, measurements of the serum

...

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
[Kidney involvement in sarcoidosis]. Rev Med Interne 2013;34(9):538-44.
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)